Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Avery

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|October 17, 2007
Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphologyMaria del Pilar Crespo, Thomas D Avery, Eric Hanssen, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in miceAnand Kumar Singh, David Ruiz, Mohd Sami Ur Rasheed, et al.
Brain, Behavior, and Immunity|September 1, 2024
18 kDa Translocator protein (TSPO) is upregulated in rat brain after peripheral nerve injury and downregulated by diroximel fumarateRafael A Cazuza, Sever M Zagrai, Anamaria R Grieco, et al.
Brain, Behavior, and Immunity|July 1, 2025
Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in miceAnand K Singh, David Ruiz, Vipul K Pandey, et al.
Journal of Medicinal Chemistry|March 19, 2004
Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activityDennis K Taylor, Thomas D Avery, Ben W Greatrex, et al.
ACS Chemical Neuroscience|July 7, 2026
Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 ActivatorsDamian L Stachura, Fátima Rivera-Escalera, Dion J L Turner, et al.
Bioorganic & Medicinal Chemistry|July 20, 2010
A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activityNathan J Stanley, Mark R Hutchinson, Trine Kvist, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRsAndrew J Harvey, Thomas D Avery, Laurent Schaeffer, et al.
Nature Biotechnology|November 4, 2024
Site-specific drug release of monomethyl fumarate to treat oxidative stress disordersThomas D Avery, Jiahe Li, Dion J L Turner, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|October 17, 2007
Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphologyMaria del Pilar Crespo, Thomas D Avery, Eric Hanssen, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in miceAnand Kumar Singh, David Ruiz, Mohd Sami Ur Rasheed, et al.
Brain, Behavior, and Immunity|September 1, 2024
18 kDa Translocator protein (TSPO) is upregulated in rat brain after peripheral nerve injury and downregulated by diroximel fumarateRafael A Cazuza, Sever M Zagrai, Anamaria R Grieco, et al.
Brain, Behavior, and Immunity|July 1, 2025
Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in miceAnand K Singh, David Ruiz, Vipul K Pandey, et al.
Journal of Medicinal Chemistry|March 19, 2004
Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activityDennis K Taylor, Thomas D Avery, Ben W Greatrex, et al.
ACS Chemical Neuroscience|July 7, 2026
Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 ActivatorsDamian L Stachura, Fátima Rivera-Escalera, Dion J L Turner, et al.
Bioorganic & Medicinal Chemistry|July 20, 2010
A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activityNathan J Stanley, Mark R Hutchinson, Trine Kvist, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRsAndrew J Harvey, Thomas D Avery, Laurent Schaeffer, et al.
Nature Biotechnology|November 4, 2024
Site-specific drug release of monomethyl fumarate to treat oxidative stress disordersThomas D Avery, Jiahe Li, Dion J L Turner, et al.
Pageof 2